Subscribe to Search results

A leaflet called "AIDS: What you must know before you give blood" was issued. It made clear for the first time that a single sexual encounter or use of injected drugs would be sufficient to prevent a person from giving blood.

Published on:

Dr Prentice attended a meeting of the Advisory Group on Hepatitis representing the SHHD. At the meeting Dr Craske reported a doubling of AIDS cases every six months in the US but there was still a very low risk of contracting the disease.

Published on:

DHSSNI officials attended a meeting of the ACVSB as observers.

Published on:

Dr Smith wrote a letter to Dr Fowler in which he suggested the importation of factor concentrates should be considered by the CSM.

Published on:

The Advisory Group on Testing for the Presence of Hepatitis B Surface Antigen and its Antibody (the Maycock Group) published a revised version of its first report.

Published on:

The Advisory Group on Testing for the Presence of Hepatitis B Surface Antigen and its Antibody considered whether to make any alterations to the methods used for testing blood donations..

Published on:

The MRC's Blood Transfusion Research Committee was reconstituted and met for the first time.

Published on:

The Maycock Group agreed to set up the Hepatitis Advisory Group (HAG). Its terms of reference were "to provide medical advice to the Chief Medical Officers of the Health Departments of the United Kingdom on all aspects of communicable hepatitis."

Published on:

A note setting out the terms of reference and proposed members of the Hepatitis Advisory Group referred to "problems relating to the management and prevention of non-A non-B hepatitis."

Published on:

At a meeting of the MRC's Blood Transfusion Research Committee, it was agreed that there was "at present no need to screen potential blood donors for non-A non-B hepatitis" but the production of a vaccine would be waited with interest, and that it would be valuable to follow-up transfusion patients previously found to have a raised serum level.

Published on:

At a meeting of the MRC's Blood Transfusion Research Committee Dr Gunson thought the committee needed to "justify its existence", whilst the DHSS favoured its continuance.

Published on:

At the UKHCDO annual meeting there was a passing discussion of AIDS. No DHSS officials were present.

Published on:

The inaugural meeting of the UK Working Party on Transfusion-Associated Hepatitis took place. It was agreed that a request would be made for a member of the DHSS's Advisory Group on Hepatitis to attend meetings.

Published on:

At the inaugural meeting of the UK Working Party on Transfusion-Associated Hepatitis it was decided that they should collate data which determined the importance of NANBH in the UK and should consider the implications of surrogate markers.

Published on:

The Central Blood Laboratories Authority held its first meeting. AIDS was not discussed.

Published on:

The Advisory Committee on the National Blood Transfusion Service met at the DHSS. There was no discussion about AIDS.

Published on:

At the fourth meeting of the Central Blood Laboratories Authority, there was a brief discussion of AIDS.

Published on:

Dr Lane wrote a memo to BPL colleagues following a Central Blood Laboratories Authority meeting summarising the discussion that occurred on AIDS.

Published on:

In his report on AIDS, Dr Lane was of the view that it was impracticable for BPL to switch to producing small pool freeze-dried cryoprecipitate.

Published on:

Dr Lane's report on AIDS was considered at a Central Blood Laboratories Authority meeting

Published on: